Sign in
Groups
Researchers
Results
GUILLERMO
LÓPEZ VIVANCO
Researcher to 2022
Pfizer (United States)
Nueva York, Estados Unidos
You are in
Collaborations
Pfizer (United States)
Publications in collaboration with researchers from Pfizer (United States) (1)
2022
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de